Antimicrobial Resistance Trends in Urinary Tract Infections in 6 African Countries

Which Medications Increase Heat-Related Risk in Patients?

Improving patient safety through medicine risk communication: a theory-informed evaluation approach

AI and machine learning for predicting in vitro/preclinical drug toxicities and adverse events in clinical patients

Pharmacovigilance Signals and Determinants of Adverse Events Linked to Inhaled Asthma Medications: A Retrospective Analysis Using the FAERS Database

Pharmacovigilance in Antituberculosis Treatment: Ensuring Safety in Tuberculosis Management

How Machine Learning Can Help Close Evidence Gaps for Drug Safety in Pregnant Women

Neoplasm Adverse Events Associated With Anti-Type 2 Biologics: An FAERS Database Pharmacovigilance Analysis Study

Interpol alerta del auge de antiparasitarios veterinarios promovidos como tratamientos contra el cáncer en humanos

Deviations from recommended use of liposomal bupivacaine: a real-world pharmacovigilance study using the FAERS database

Knowledge Graph for Cardiovascular Drug Safety and Pharmacovigilance: A Scoping Review

79th World Health Assembly adopts resolution to strengthen pharmacovigilance

Real-world pharmacovigilance analysis of drug-induced liver injury in 18-65 years: Based on the FDA adverse event reporting system (FAERS)

Adverse Drug Reaction Costs and Study Quality in Africa: A Systematic Review of Cost-of-Illness Studies

Sex-specific risk profiles of drug-associated joint stiffness and deformity: a FAERS-based pharmacovigilance study with Canadian Vigilance Adverse Reaction Database validation

Quality of adverse drug reaction reports submitted to the national pharmacovigilance center of Nepal: a pre-and post-training evaluation

WHO and African Medicines Agency launch landmark framework to strengthen access to quality-assured health products in Africa

Adverse Effects and Treatment Discontinuation of Blood Pressure–Lowering Drugs and Combinations. A Network Meta-Analysis

Minimizing Adverse Effects in Hypertension Treatment

The High Stakes of Pharmacovigilance: Why Specialized Partnership Outperforms the Large CRO Model